content

EMA Develops A Quality Control Group To Aid Drug Development

To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices...

Amarin Goes for Growth with New UK and Ireland General Manager

Amarin Pharmaceuticals Ireland Limited plans to drive forward the next phase of its commercial expansion with the major new appointment of Scott Curley to...

An Identification Result Doesn’t End at the Report

You are evaluating your identification results for an unknown isolate โ€“ what does this organism mean to your manufacturing process, your final product, and...

RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore

RVAC Medicines Pte. Ltd.ย (RVAC), a messenger RNA (mRNA) technology platform company incubated byย CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and theย Agency...

CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore Pharma Market by 2030

Continuing the winning streak of CPhI & P-MEC India, Informa Markets, the leading international B2B events group is once again back with its 15th...

Merck Invests โ‚ฌ 290 Million in U.S. Drug Safety Testing Capacity

Merck, a leading science and technology company, invests more than โ‚ฌ 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will...

Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems

The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally. The Food and Agriculture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read